VanEck Bionic Engineering UCITS ETF A

ISIN IE0005TF96I9

 | 

Ticker CYBG

TER
0.55% p.a.
Distribution policy
Accumulating
Replication
Full replication
Fund size
5 m
Holdings
25
 

Overview

Description

The VanEck Bionic Engineering UCITS ETF A seeks to track the MVIS Global Bionic Healthcare ESG index. The MVIS Global Bionic Healthcare ESG index tracks companies worldwide that are involved in bionic healthcare industries. This includes companies that generate a significant share of their revenue in the following areas: Medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
 
The ETF's TER (total expense ratio) amounts to 0.55% p.a.. The VanEck Bionic Engineering UCITS ETF A is the only ETF that tracks the MVIS Global Bionic Healthcare ESG index. The ETF replicates the performance of the underlying index by full replication (buying all the index constituents). The dividends in the ETF are accumulated and reinvested in the ETF.
 
The VanEck Bionic Engineering UCITS ETF A is a very small ETF with 5m GBP assets under management. The ETF was launched on 2 December 2022 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Fund size
GBP 5 m
Total expense ratio
0.55% p.a.
Replication Physical (Full replication)
Legal structure ETF
Strategy risk Long-only
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in GBP)
17.20%
Inception/ Listing Date 2 December 2022
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Fund Provider VanEck
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Indextype -
Swap counterparty -
Collateral manager
Securities lending No
Securities lending counterparty

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the VanEck Bionic Engineering UCITS ETF A.
Similar ETFs via ETF search
How do you like our new ETF profile? Here you'll find our Questionnaire.

Holdings

Below you find information about the composition of the VanEck Bionic Engineering UCITS ETF A.

Top 10 Holdings

Weight of top 10 holdings
out of 25
68.24%
Edwards Lifesciences Corp
11.00%
Stryker
10.92%
Medtronic
9.50%
DexCom
8.79%
Zimmer Biomet Holdings
7.12%
Sonova Holding
4.98%
Straumann Holding
4.53%
Smith & Nephew
4.34%
Cochlear
3.73%
Globus Medical
3.33%

Countries

United States
66.40%
Switzerland
9.52%
Ireland
9.50%
Australia
3.73%
Other
10.85%
Show more

Sectors

Health Care
95.66%
Other
4.34%
As of 29/02/2024

Performance

Returns overview

YTD +5.77%
1 month +2.32%
3 months +5.90%
6 months +22.82%
1 year -1.49%
3 years -
5 years -
Since inception (MAX) +4.68%
2023 -1.03%
2022 -
2021 -
2020 -

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 17.20%
Volatility 3 years -
Volatility 5 years -
Return per risk 1 year -0.09
Return per risk 3 years -
Return per risk 5 years -
Maximum drawdown 1 year -26.39%
Maximum drawdown 3 years -
Maximum drawdown 5 years -
Maximum drawdown since inception -26.39%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
gettex EUR CIB0 -
-
-
-
-
Borsa Italiana EUR CYBO -
-
-
-
-
Borsa Italiana EUR - CYBO IM
CYBOUSIV
CYBO.MI
CYBOEURINAV=IHSM
London Stock Exchange GBP CYBG CYBG LN
VVCYBG.L
London Stock Exchange USD CYBO CYBO LN
CYBOUSIV
CYBO.L
CYBOEURINAV=IHSM
SIX Swiss Exchange CHF CYBO CYBO SE
CYBO.S
XETRA EUR CIB0 CIB0 GY
CYBOUSIV
CIB0.DE
CYBOEURINAV=IHSM

Further information

Further ETFs with similar investment focus

Fund name Fund Size in m € (AuM) TER p.a. Distribution Replication
iShares Ageing Population UCITS ETF 442 0.40% p.a. Accumulating Sampling

Frequently asked questions

What is the name of CYBG?

The name of CYBG is VanEck Bionic Engineering UCITS ETF A.

What is the ticker of VanEck Bionic Engineering UCITS ETF A?

The primary ticker of VanEck Bionic Engineering UCITS ETF A is CYBG.

What is the ISIN of VanEck Bionic Engineering UCITS ETF A?

The ISIN of VanEck Bionic Engineering UCITS ETF A is IE0005TF96I9.

What are the costs of VanEck Bionic Engineering UCITS ETF A?

The total expense ratio (TER) of VanEck Bionic Engineering UCITS ETF A amounts to 0.55% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is VanEck Bionic Engineering UCITS ETF A paying dividends?

VanEck Bionic Engineering UCITS ETF A is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of VanEck Bionic Engineering UCITS ETF A?

The fund size of VanEck Bionic Engineering UCITS ETF A is 5m GBP. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.